Concepedia

Second Malignancy Surveillance

Second Malignancy Surveillance is a clinical monitoring strategy within tumor follow-up that specifically involves the systematic detection and evaluation of new, independent malignant neoplasms distinct from the primary cancer in cancer survivors.

185

Publications

10.6K

Citations

1.2K

Authors

440

Institutions

Publications per year

2017–2026

46

Parents

Publications

185

Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance

Feiran Lou, James Huang, Camelia S. Sima et al. · Journal of Thoracic and Cardiovascular Surgery · 2012 · 332 citations · Full text

, , +16

Risk of second tumors in survivors of childhood cancer

Frederick P. Li, J. Robert Cassady, Norman Jaffe · Cancer · 1975 · 266 citations · Full text

, , +17

Sarcoma as a second malignancy after treatment for breast cancer

Johnny Yap, Paul J. Chuba, Ron Thomas et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 264 citations

, , +14

Second malignancies following testicular cancer, ovarian cancer and hodgkin's disease: An international collaborative study among cancer registries

John Kaldor, Nicholas Day, Pierre R. Band et al. · International Journal of Cancer · 1987 · 257 citations

, , +12

Incidence of Second Neoplasms in Patients with Bilateral Retinoblastoma

John D. Roarty, Ian W. McLean, Lorenz E. Zimmerman · Ophthalmology · 1988 · 256 citations

, , +13

1–5 of 185

Authors

1.2K

  1. RE
    Rochelle E. Curtis

    National Cancer Institute, United States

    6 publications · 890 citations

    6

    h-index

  2. RD
    Randy D. Gascoyne

    BC Cancer Agency, Canada

    3 publications · 217 citations

    3

    h-index

  3. ­P
    ­Eero Pukkala

    Finnish Cancer Registry, Finland

    3 publications · 340 citations

    3

    h-index

  4. LB
    Lois B. Travis

    National Cancer Institute, United States

    3 publications · 366 citations

    3

    h-index

  5. JF
    Joseph F. Fraumeni

    National Cancer Institute, United States

    3 publications · 489 citations

    3

    h-index

1–5 of 1.2K

Institutions

440

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    8 h-index

    56 publications

    5.8K citations

  2. Memorial Sloan Kettering Cancer Center

    New York, United States

    7 h-index

    35 publications

    4.5K citations

  3. National Cancer Institute

    Bethesda, United States

    7 h-index

    19 publications

    3.5K citations

  4. BC Cancer Agency

    Vancouver, Canada

    7 h-index

    39 publications

    2.9K citations

  5. Harvard University

    Cambridge, United States

    7 h-index

    23 publications

    1.6K citations

  6. University of Chicago

    Chicago, United States

    5 h-index

    16 publications

    1.6K citations

  7. National Institutes of Health

    Bethesda, United States

    5 h-index

    14 publications

    2.5K citations

  8. Cancer Registry of Norway

    Oslo, Norway

    4 h-index

    4 publications

    661 citations

1–8 of 440

Venues

  1. PubMed

    Repository · 17 publications · 690 citations

    13

    h-index

  2. 9

    h-index

  3. Cancer

    7 publications · 746 citations

    8

    h-index

  4. Annals of Oncology

    8 publications · 889 citations

    8

    h-index

  5. British Journal of Cancer

    BJC · 6 publications · 531 citations

    6

    h-index

1–5